Have you read these stories?

Why cutting share of states to fund defence is a bad idea

The shift in the fiscal centre of gravity means that things that constrain states’ finances would worsen the slump.


Sep 18, 2019, 03.02 AM IST



Glenmark gets final nod from USFDA for angina treatment drug

The product is a generic version of Gilead Sciences Inc's Ranexa extended-release tablets in the same strengths.

Banks, oil and gas majors may lead 15-20% earnings growth this quarter: Mayuresh Joshi

The markets might remain very volatile in shor term, s...

Sell Lupin, target Rs 800: Elara Capital

Sell Lupin at a price target of Rs 800.

ET Prime Distribution
Load More...

Other useful Links

Copyright © 2019 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service